Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METOPROLOL SUCCINATE USP (PROCESS-II), with a corresponding US DMF Number 19638.
Remarkably, this DMF maintains an Active status since its submission on August 24, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 25, 2013, and payment made on June 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II